By Mak Yuen Teen I am dismayed, but not totally surprised, with the report in the Business Times today (March 23) titled “SGX says no conflict of interest with expanded research unit”. SGX can say what it likes, but...
Read More
Putting Wayco deal, recent appointment of directors together with a review of other past events carry the risk of diluting the depth of the review with regards to what’s relevant.
Read MoreI believe that SGX and other regulators need to examine whether the disclosure and accounting practices of Noble, and the actions of directors and key officers, have complied with listing requirements, securities laws and other regulation. Investors and observers around the world are watching to see if our actions match our reputation.
Read MoreIts results and deal announcements seem to contain incredulous numbers and information gaps.
Read MoreSGX has a responsibility to look beyond the interests of its own shareholders and consider the interests of other stakeholders. An important group of stakeholders are investors in companies listed on SGX.
Read More
